Health economic evaluation of novel drug delivery agent in breast cancer brain metastases
Summary Breast cancer brain metastases (BCBM) occur when cancer cells spread from the breast to the brain and represent a substantial clinical and economic challenge for the NHS. mutTNF (mutant tumour necrosis factor) is a novel therapy designed to temporarily open the blood–brain barrier at sites of brain metastases, improving the delivery of treatments to […]